Literature DB >> 17998063

Macrophage migration inhibitory factor manipulation and evaluation in tumoral hypoxic adaptation.

Millicent Winner1, Lin Leng, Wayne Zundel, Robert A Mitchell.   

Abstract

Increasingly clear is an important regulatory role for hypoxia-inducible factor 1alpha (HIF-1alpha) in the expression of the cytokine/growth factor macrophage migration inhibitory factor (MIF). The functional significance of hypoxia-induced MIF expression is revealed by findings demonstrating that HIF-1alpha-dependent MIF expression is necessary for hypoxia-induced evasion from cell senescence and that MIF is necessary for HIF-1alpha stabilization induced by hypoxia and prolyl hydroxylase (PHD) inhibitors. Both of these activities attributed to MIF likely involve the modulation of protein degratory pathways mediated by cullin-dependent E3 ubiquitin ligase complexes and their regulation by the COP9 signalosome (CSN). As the importance of MIF in hypoxic adaptation of human tumors is now becoming fully realized, we review protocols designed to evaluate MIF expression, activity, and functional consequences in hypoxic environments.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17998063      PMCID: PMC2943948          DOI: 10.1016/S0076-6879(07)35018-0

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  32 in total

Review 1.  The COP9 signalosome: an assembly and maintenance platform for cullin ubiquitin ligases?

Authors:  Dieter A Wolf; Chunshui Zhou; Susan Wee
Journal:  Nat Cell Biol       Date:  2003-12       Impact factor: 28.824

2.  Amplification of tumor hypoxic responses by macrophage migration inhibitory factor-dependent hypoxia-inducible factor stabilization.

Authors:  Millicent Winner; Albert C Koong; Beatriz E Rendon; Wayne Zundel; Robert A Mitchell
Journal:  Cancer Res       Date:  2007-01-01       Impact factor: 12.701

3.  Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1.

Authors:  R Kleemann; A Hausser; G Geiger; R Mischke; A Burger-Kentischer; O Flieger; F J Johannes; T Roger; T Calandra; A Kapurniotu; M Grell; D Finkelmeier; H Brunner; J Bernhagen
Journal:  Nature       Date:  2000-11-09       Impact factor: 49.962

4.  Distinct aerobic and hypoxic mechanisms of HIF-alpha regulation by CSN5.

Authors:  Lynne Bemis; Denise A Chan; Carla V Finkielstein; Lin Qi; Patrick D Sutphin; Xiaojiang Chen; Kurt Stenmark; Amato J Giaccia; Wayne Zundel
Journal:  Genes Dev       Date:  2004-04-01       Impact factor: 11.361

5.  Macrophage migration inhibitory factor and CXC chemokine expression in non-small cell lung cancer: role in angiogenesis and prognosis.

Authors:  Eric S White; Kevin R Flaherty; Shannon Carskadon; Ashley Brant; Mark D Iannettoni; John Yee; Mark B Orringer; Douglas A Arenberg
Journal:  Clin Cancer Res       Date:  2003-02       Impact factor: 12.531

Review 6.  The von Hippel-Lindau tumor suppressor protein: new insights into oxygen sensing and cancer.

Authors:  William Kim; William G Kaelin
Journal:  Curr Opin Genet Dev       Date:  2003-02       Impact factor: 5.578

7.  Macrophage migration inhibitory factor (MIF) gene polymorphism is associated with susceptibility to but not severity of inflammatory polyarthritis.

Authors:  A Barton; R Lamb; D Symmons; A Silman; W Thomson; J Worthington; R Donn
Journal:  Genes Immun       Date:  2003-10       Impact factor: 2.676

8.  A functional promoter polymorphism in the macrophage migration inhibitory factor (MIF) gene associated with disease severity in rheumatoid arthritis.

Authors:  J A Baugh; S Chitnis; S C Donnelly; J Monteiro; X Lin; B J Plant; F Wolfe; P K Gregersen; R Bucala
Journal:  Genes Immun       Date:  2002-05       Impact factor: 2.676

9.  Structural basis for the recognition of hydroxyproline in HIF-1 alpha by pVHL.

Authors:  Wai-Ching Hon; Michael I Wilson; Karl Harlos; Timothy D W Claridge; Christopher J Schofield; Christopher W Pugh; Patrick H Maxwell; Peter J Ratcliffe; David I Stuart; E Yvonne Jones
Journal:  Nature       Date:  2002-06-05       Impact factor: 49.962

Review 10.  Mechanisms and effectors of MIF-dependent promotion of tumourigenesis.

Authors:  Robert A Mitchell
Journal:  Cell Signal       Date:  2004-01       Impact factor: 4.315

View more
  7 in total

Review 1.  Stromal-dependent tumor promotion by MIF family members.

Authors:  Robert A Mitchell; Kavitha Yaddanapudi
Journal:  Cell Signal       Date:  2014-09-30       Impact factor: 4.315

2.  Macrophage migration inhibitory factor-CXCR4 is the dominant chemotactic axis in human mesenchymal stem cell recruitment to tumors.

Authors:  Sofia Lourenco; Vitor H Teixeira; Tammy Kalber; Ricardo J Jose; R Andres Floto; Sam M Janes
Journal:  J Immunol       Date:  2015-02-23       Impact factor: 5.422

3.  Cooperative regulation of non-small cell lung carcinoma angiogenic potential by macrophage migration inhibitory factor and its homolog, D-dopachrome tautomerase.

Authors:  Arlixer M Coleman; Beatriz E Rendon; Ming Zhao; Ming-Wei Qian; Richard Bucala; Dan Xin; Robert A Mitchell
Journal:  J Immunol       Date:  2008-08-15       Impact factor: 5.422

Review 4.  A multi-targeted approach to suppress tumor-promoting inflammation.

Authors:  Abbas K Samadi; Alan Bilsland; Alexandros G Georgakilas; Amedeo Amedei; Amr Amin; Anupam Bishayee; Asfar S Azmi; Bal L Lokeshwar; Brendan Grue; Carolina Panis; Chandra S Boosani; Deepak Poudyal; Diana M Stafforini; Dipita Bhakta; Elena Niccolai; Gunjan Guha; H P Vasantha Rupasinghe; Hiromasa Fujii; Kanya Honoki; Kapil Mehta; Katia Aquilano; Leroy Lowe; Lorne J Hofseth; Luigi Ricciardiello; Maria Rosa Ciriolo; Neetu Singh; Richard L Whelan; Rupesh Chaturvedi; S Salman Ashraf; H M C Shantha Kumara; Somaira Nowsheen; Sulma I Mohammed; W Nicol Keith; William G Helferich; Xujuan Yang
Journal:  Semin Cancer Biol       Date:  2015-05-05       Impact factor: 15.707

5.  Oxidized macrophage migration inhibitory factor is a potential new tissue marker and drug target in cancer.

Authors:  Alexander Schinagl; Michael Thiele; Patrice Douillard; Dirk Völkel; Lukas Kenner; Zahra Kazemi; Michael Freissmuth; Friedrich Scheiflinger; Randolf J Kerschbaumer
Journal:  Oncotarget       Date:  2016-11-08

Review 6.  MIF-Dependent Control of Tumor Immunity.

Authors:  Jordan T Noe; Robert A Mitchell
Journal:  Front Immunol       Date:  2020-11-25       Impact factor: 7.561

Review 7.  Macrophage migration inhibitory factor (MIF) in the development and progression of pulmonary arterial hypertension.

Authors:  Mohamed Ahmed; Edmund Miller
Journal:  Glob Cardiol Sci Pract       Date:  2018-06-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.